Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Romain Guiho

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Future Oncology (London, England)|February 13, 2015
TRAIL-based therapy in pediatric bone tumors: how to overcome resistanceRomain Guiho, Kevin Biteau, Dominique Heymann, et al.
Neuropathology and Applied Neurobiology|December 30, 2020
Cell senescence in neuropathology: A focus on neurodegeneration and tumoursGabriela Carreno, Romain Guiho, Juan Pedro Martinez-Barbera
Oncotarget|August 21, 2014
Clusterin inhibition using OGX-011 synergistically enhances zoledronic acid activity in osteosarcomaFrancois Lamoureux, Marc Baud'huin, Benjamin Ory, et al.
American Journal of Cancer Research|May 7, 2016
L-MTP-PE and zoledronic acid combination in osteosarcoma: preclinical evidence of positive therapeutic combination for clinical transferKevin Biteau, Romain Guiho, Mathias Chatelais, et al.
Cancers|November 26, 2022
TRAIL-Based Therapies Efficacy in Pediatric Bone Tumors Models Is Modulated by TRAIL Non-Apoptotic Pathway Activation via RIPK1 RecruitmentRégis Brion, Malika Gantier, Kevin Biteau, et al.
International Journal of Cancer|August 26, 2016
TRAIL delivered by mesenchymal stromal/stem cells counteracts tumor development in orthotopic Ewing sarcoma modelsRomain Guiho, Kevin Biteau, Giulia Grisendi, et al.
Aging Cell|March 17, 2020
Galactose-modified duocarmycin prodrugs as senolyticsAna Guerrero, Romain Guiho, Nicolás Herranz, et al.
Cytotherapy|August 11, 2018
In vitro and in vivo discrepancy in inducing apoptosis by mesenchymal stromal cells delivering membrane-bound tumor necrosis factor-related apoptosis inducing ligand in osteosarcoma pre-clinical modelsRomain Guiho, Kevin Biteau, Giulia Grisendi, et al.
Oral Diseases|February 20, 2024
Zoledronic acid enhances tumor growth and metastatic spread in a mouse model of jaw osteosarcomaThan-Thuy Nham, Romain Guiho, Régis Brion, et al.
Molecular Cancer Research : MCR|January 20, 2012
A functional, new short isoform of death receptor 4 in Ewing's sarcoma cell lines may be involved in TRAIL sensitivity/resistance mechanismsGaëlle Picarda, Sylvanie Surget, Romain Guiho, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Future Oncology (London, England)|February 13, 2015
TRAIL-based therapy in pediatric bone tumors: how to overcome resistanceRomain Guiho, Kevin Biteau, Dominique Heymann, et al.
Neuropathology and Applied Neurobiology|December 30, 2020
Cell senescence in neuropathology: A focus on neurodegeneration and tumoursGabriela Carreno, Romain Guiho, Juan Pedro Martinez-Barbera
Oncotarget|August 21, 2014
Clusterin inhibition using OGX-011 synergistically enhances zoledronic acid activity in osteosarcomaFrancois Lamoureux, Marc Baud'huin, Benjamin Ory, et al.
American Journal of Cancer Research|May 7, 2016
L-MTP-PE and zoledronic acid combination in osteosarcoma: preclinical evidence of positive therapeutic combination for clinical transferKevin Biteau, Romain Guiho, Mathias Chatelais, et al.
Cancers|November 26, 2022
TRAIL-Based Therapies Efficacy in Pediatric Bone Tumors Models Is Modulated by TRAIL Non-Apoptotic Pathway Activation via RIPK1 RecruitmentRégis Brion, Malika Gantier, Kevin Biteau, et al.
International Journal of Cancer|August 26, 2016
TRAIL delivered by mesenchymal stromal/stem cells counteracts tumor development in orthotopic Ewing sarcoma modelsRomain Guiho, Kevin Biteau, Giulia Grisendi, et al.
Aging Cell|March 17, 2020
Galactose-modified duocarmycin prodrugs as senolyticsAna Guerrero, Romain Guiho, Nicolás Herranz, et al.
Cytotherapy|August 11, 2018
In vitro and in vivo discrepancy in inducing apoptosis by mesenchymal stromal cells delivering membrane-bound tumor necrosis factor-related apoptosis inducing ligand in osteosarcoma pre-clinical modelsRomain Guiho, Kevin Biteau, Giulia Grisendi, et al.
Oral Diseases|February 20, 2024
Zoledronic acid enhances tumor growth and metastatic spread in a mouse model of jaw osteosarcomaThan-Thuy Nham, Romain Guiho, Régis Brion, et al.
Molecular Cancer Research : MCR|January 20, 2012
A functional, new short isoform of death receptor 4 in Ewing's sarcoma cell lines may be involved in TRAIL sensitivity/resistance mechanismsGaëlle Picarda, Sylvanie Surget, Romain Guiho, et al.
Pageof 3